On June 25, 2025, Brainstorm Cell Therapeutics Inc. held its Annual Meeting where shareholders approved increasing the stock option pool by 2,000,000 shares, now totaling 2,906,666 shares. Additionally, the board members were elected and Brightman Almagor Zohar & Co. was ratified as their accounting firm for FY 2025.